All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @coachburak on Instagram · 87s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @coachburak's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Good evening, my welcome to the
  2. 0:13future.
  3. 0:14I am proud to welcome more prizes, I'll tell you what it is for your next year.
  4. 0:18And this is my moved experience.
  5. 0:21I would miss you very much.
  6. 0:26You all will see thatander.
  7. 0:28This helps.
  8. 0:29Here we are in the studio.
  9. 0:31We are here to talk about the association of testosterone treatment with elevation of
  10. 0:37depressive symptoms in men.
  11. 0:40In the studio, we are here to talk about the relationship between men and men.
  12. 0:46We are here to talk about the relationship between men and men.
  13. 0:51We are here to talk about the relationship between men and men.
  14. 0:56We are here to go to cash transfers.
  15. 0:59I share this to all of you.
  16. 1:01In any meaning, at least a small amount of estimated
  17. 1:10hormones of mole, Zealand, and Europe.
  18. 1:15And in be honest,
  19. 1:18drugs and plasticsm dirty products have been Jacob.
  20. 1:24enable the sooner, Windows and Flips.

@coachburak's testosterone depression claims, fact-checked

Burak Olgun

Instagram creator

5.1K viewsView on Instagram

Quick answer

The transcript references 'the association of testosterone treatment with elevation of depressive symptoms in men,' which appears to reference published research on TRT and mood outcomes. However, the spoken content is too incoherent to extract specific clinical claims, so the fact-check is based on the caption's assertions about age-related testosterone decline and its psychological effects. The caption's framing conflates normal age-related decline with clinical hypogonadism, a distinction that matters significantly for treatment decisions.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @coachburak's testosterone depression claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@coachburak's testosterone depression claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@coachburak's testosterone depression claims, fact-checked" from Burak Olgun. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The transcript references 'the association of testosterone treatment with elevation of depressive symptoms in men,' which appears to reference published research on TRT and mood outcomes.

The reason this review is not generic is the source wording and the canonical claim label "trt testosteron ist mehr als muskelkraft und bartwuchs es steue." In this clip, the useful excerpt is: "Good evening, my welcome to the future." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The largest RCT of TRT to date, the TRAVERSE trial (Lincoff et al.
People who land here are usually comparing the Testosterone claim with trt, testosteron, and hormonbalance.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The transcript references 'the association of testosterone treatment with elevation of depressive symptoms in men,' which appears to reference published research on TRT and mood outcomes.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The transcript references 'the association of testosterone treatment with elevation of depressive symptoms in men,' which appears to reference published research on TRT and mood outcomes. However, the spoken content is too incoherent to extract specific clinical claims, so the fact-check is based on the caption's assertions about age-related testosterone decline and its psychological effects. The caption's framing conflates normal age-related decline with clinical hypogonadism, a distinction that matters significantly for treatment decisions.
  • Testosterone declines approximately 1% per year after age 30, confirmed by the Baltimore Longitudinal Study of Aging (Harman et al., 2001), but this does not automatically equal clinical hypogonadism.
  • The largest RCT of TRT to date, the TRAVERSE trial (Lincoff et al., 2023, NEJM), focused on cardiovascular safety and showed modest, not dramatic, quality-of-life improvements.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Testosterone declines approximately 1% per year after age 30, confirmed by the Baltimore Longitudinal Study of Aging (Harman et al., 2001), but this does not automatically equal clinical hypogonadism.
  • The largest RCT of TRT to date, the TRAVERSE trial (Lincoff et al., 2023, NEJM), focused on cardiovascular safety and showed modest, not dramatic, quality-of-life improvements.
  • A 2016 Cochrane review found that TRT's effect on mood in men with low-normal testosterone was weak, meaning numbers alone are not a sufficient reason to treat.
  • Clinical hypogonadism requires both low serum testosterone and symptoms. Testing only total testosterone, without free testosterone and SHBG, gives an incomplete picture.
  • TRT suppresses natural testosterone production and can cause infertility, erythrocytosis, and testicular atrophy. These risks should be part of any informed conversation.
  • The transcript in this video is largely unintelligible, which means the caption is doing most of the persuasive work without being supported by coherent spoken evidence.
  • If you are experiencing mood changes, fatigue, or low libido, testosterone is worth investigating, but so are sleep apnea, thyroid dysfunction, and depression, which can mimic low-T symptoms.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @coachburak actually say?

Honestly, this is a tough one to fact-check, because the transcript is nearly incoherent. The caption makes specific, testable claims: testosterone drops 1-2% per year after 30, low T wrecks your mood and sleep, and a "groundbreaking" JAMA study backs this up. The actual spoken content is largely unintelligible, with phrases like "drugs and plastics, dirty products have been Jacob" and references to "cash transfers." So we are primarily fact-checking the caption and the implied framing.

The caption's central argument is that testosterone decline is a slow erosion of identity: "You lose yourself." That is a dramatic claim. It is also one that does real work in the TRT marketing space, framing a gradual physiological process as an existential crisis requiring intervention. We should be skeptical of that framing even when the underlying biology is partially real.

Does the science back this up?

The 1-2% annual decline figure is broadly supported, but the emotional consequences are far less clear-cut than the caption implies. The JAMA study referenced is almost certainly the 2023 Testosterone Replacement in Men with Hypogonadism (TRAVERSE) trial or the 2019 Snyder et al. data, both of which show modest effects on mood at best.

The TRAVERSE trial (Lincoff et al., 2023, NEJM/JAMA) was the largest randomized controlled trial of TRT to date, and it showed cardiovascular safety data, not dramatic mood transformation. On depressive symptoms specifically, a 2019 meta-analysis by Zarrouf et al. in the Journal of Psychiatric Practice found TRT had a statistically significant but clinically modest effect on depression scores in hypogonadal men. The effect sizes were small. A 2016 Cochrane review by Huo et al. concluded that evidence for TRT improving mood in men with normal-range testosterone was weak. So yes, there is a signal, but "you lose yourself" is a marketing line, not a clinical summary.

The 1-2% per year decline is real. Harman et al. (2001, Journal of Clinical Endocrinology and Metabolism) confirmed longitudinal testosterone decline averaging roughly 1% per year in the Baltimore Longitudinal Study of Aging. That part checks out.

What did they get wrong (or right)?

Right: The general trajectory of age-related testosterone decline is well-documented. Right: Testosterone does influence mood, sleep architecture, and motivation, those are not invented connections. Wrong: The caption implies that decline alone causes identity-level suffering, and that is a significant overreach. Most men with age-related testosterone decline do not develop clinical hypogonadism. The Endocrine Society defines hypogonadism by a combination of low serum levels AND symptomatic presentation, not numbers alone.

The framing that testosterone controls "your entire being" is the kind of reductionism that sells supplements and TRT clinics but does not reflect how hormones actually work in context. Testosterone is one variable in a system that includes cortisol, sleep quality, thyroid function, diet, activity level, and mental health history. Attributing mood and motivation entirely to testosterone, without those other variables, is misleading. The caption also teases a "groundbreaking JAMA study" without naming it, which is a classic soft-sell tactic. If the study is real, name it. If you cannot name it in a caption, you probably should not invoke it.

What should you actually know?

If you are a man over 30 experiencing fatigue, low libido, mood changes, or sleep disruption, testosterone is worth checking. It is a real biomarker and it matters. But a single blood test taken in isolation tells you very little. Total testosterone varies by time of day, recent sleep, stress, and hydration. Any credible clinician will test free testosterone, SHBG, LH, FSH, and sometimes prolactin before drawing conclusions.

TRT is an FDA-approved therapy for clinically diagnosed hypogonadism. It is not a general wellness upgrade for men whose numbers are low-normal. The TRAVERSE trial found TRT did not significantly increase cardiovascular risk in men with hypogonadism and pre-existing cardiovascular risk factors, which was the key safety question. But it also did not produce the sweeping quality-of-life improvements that content like this implies.

  • Get tested properly before assuming you are deficient.
  • Mood and motivation have many causes. Do not assume testosterone is the lever without ruling out sleep apnea, thyroid dysfunction, and depression first.
  • TRT has real side effects including fertility suppression, erythrocytosis, and testicular atrophy.
  • A telehealth provider who orders labs and reviews your full history before prescribing is doing it right. One who prescribes based on symptoms alone is not.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Burak Olgun · Instagram creator

5.1K views on this video

Testosteron ist mehr als Muskelkraft und Bartwuchs. Es steuert deine Stimmung, deinen Schlaf, deine Motivation – dein gesamtes Sein. Ab 30 verlierst du jährlich 1–2 % deines Testosterons. Was passier

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about testosterone declines approximately 1% per year after age 30, confirmed?

Testosterone declines approximately 1% per year after age 30, confirmed by the Baltimore Longitudinal Study of Aging (Harman et al., 2001), but this does not automatically equal clinical hypogonadism.

What does the video say about the largest rct of trt to date, the traverse trial?

The largest RCT of TRT to date, the TRAVERSE trial (Lincoff et al., 2023, NEJM), focused on cardiovascular safety and showed modest, not dramatic, quality-of-life improvements.

What does the video say about a 2016 cochrane review found?

A 2016 Cochrane review found that TRT's effect on mood in men with low-normal testosterone was weak, meaning numbers alone are not a sufficient reason to treat.

What does the video say about clinical hypogonadism requires both low serum testosterone?

Clinical hypogonadism requires both low serum testosterone and symptoms. Testing only total testosterone, without free testosterone and SHBG, gives an incomplete picture.

What does the video say about trt suppresses natural testosterone production?

TRT suppresses natural testosterone production and can cause infertility, erythrocytosis, and testicular atrophy. These risks should be part of any informed conversation.

What does the video say about the transcript in this video?

The transcript in this video is largely unintelligible, which means the caption is doing most of the persuasive work without being supported by coherent spoken evidence.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Burak Olgun, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.